Analyst Ratings For NYSE:EVH – Evolent Health (NYSE:EVH)
Today, KeyCorp raised its price target on NYSE:EVH – Evolent Health (NYSE:EVH) to per share.
Some recent analyst ratings include
- 6/4/2018-Piper Jaffray Companies initiated coverage with a Overweight rating.
- 1/4/2018-Citigroup initiated coverage with a Buy rating.
- 12/3/2017-Cantor Fitzgerald Reiterated Rating of Buy.
- On 6/4/2018 Seth Blackley, President, sold 16,666 with an average share price of $20.45 per share and the total transaction amounting to $340,819.70.
- On 6/1/2018 Frank J. Williams, CEO, sold 15,000 with an average share price of $20.04 per share and the total transaction amounting to $300,600.00.
- On 6/1/2018 Thomas Peterson III, COO, sold 10,000 with an average share price of $20.04 per share and the total transaction amounting to $200,400.00.
- On 6/1/2018 Unitedhealth Group Inc, Director, sold 2,861,065 with an average share price of $19.23 per share and the total transaction amounting to $55,018,279.95.
- On 5/22/2018 Jonathan Weinberg, General Counsel, sold 15,000 with an average share price of $20.02 per share and the total transaction amounting to $300,300.00.
- On 5/21/2018 Seth Blackley, President, sold 16,666 with an average share price of $19.39 per share and the total transaction amounting to $323,153.74.
- On 5/10/2018 Seth Blackley, President, sold 64,398 with an average share price of $17.63 per share and the total transaction amounting to $1,135,336.74.
Recent Trading Activity for NYSE:EVH – Evolent Health (NYSE:EVH)
Shares of NYSE:EVH – Evolent Health closed the previous trading session at 22.10 up +0.45 2.08% with 21.950000762939453 shares trading hands.